AGILENT TECHNOLOGIES in Electrophoresis Products

Agilent has a strong focus on R&D activities. The company's R&D efforts are centered on potential new products and product improvements covering a wide variety of technologies. Due to the strong research and development capabilities, the company has been able to launch a number of products in the recent past. Agilent incurred R&D expenditures of USD 329 million in 2016, USD 330 million in 2015, and USD 358 million in 2014. The R&D expenditure accounted for 7.9% of the total revenue in 2016. The company launched SurePrint gene expression microarrays for messenger RNA profiling in 2015. Agilent is one of the major providers of capillary electrophoresis systems. Agilent 7100 capillary electrophoresis system is the flagship products in the capillary electrophoresis market. With automated technology incorporated this product becomes a preferred choice for pharmaceutical and biotechnological companies. The global bioinformatics market is expected to grow rapidly in the coming years. The need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics and proteomics is an opportunity for the company to develop the new products. Source: MarketsandMarkets Analysis